Amrize
Amrize's revenue rose 0.9% to $11.8 billion in fiscal 2025. Its operating margin was 16.1%, down from 18.8% a year earlier. Free cash flow was $1.4 billion, down 13.4%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
What Amrize does
Amrize sells building materials and roofing and wall products in the United States and Canada. Its products include cement, aggregates (crushed stone, sand and gravel), ready-mix concrete, asphalt, roofing systems, insulation and coatings. It sells to home builders, commercial builders, architects, distributors, contractors and government authorities, for new construction and for repairs and refurbishment.
The company reports two segments. Building Materials sells cement, aggregates, ready-mix concrete and asphalt. Building Envelope sells roofing and wall systems under brands such as Duro-Last, Elevate and Malarkey. In Building Envelope, most revenue comes through a few large distributors. Amrize says it competes in a highly competitive industry.
Amrize says its 19,000 employees work across 1,000 sites in the United States, Canada, Colombia, Switzerland and Jamaica, serving 23,000 customers. It became a separate public company in June 2025, when Holcim distributed its shares to Holcim's shareholders.
Its biggest risks, as it describes them
- Swings in construction demand, since it and its customers work in cyclical industries and regional markets.
- Higher costs or shortages of raw materials, energy and fuel.
- Failing to compete effectively in a highly competitive industry.
- Trouble integrating acquisitions or joint ventures, or not getting the benefits it expects.
- Losing, or facing price pressure from, key customers or distributors.
Income statement
From fiscal 2023 to 2025, earnings per share grew 11.2% a year and net income 11.3% a year, with the share count about the same.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | 1,107 | 1,585 | 1,922 |
| Debt incl. finance leases | — | — | — |
| Net debt (negative means net cash) | — | — | — |
| Net debt to EBITDA | — | — | — |
| Debt to equity | — | — | — |
| Interest coverage | 3.4x | 4.0x | 4.1x |
| Current ratio | — | 1.9x | 1.6x |
| Quick ratio | — | 1.3x | 1.1x |
Cash flow
Projections
Project Amrize's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 12 insiders bought $9.9 million of Amrize shares on the open market, and none sold any.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Jan Philipp JenischChairman & CEO, Director | Bought | 30,000 | $42.47 | $1.3 million | Form 4 |
| Aug 27, 2026 | Dwight Audley Konrad GibsonDirector | Bought | 5 | $44.58 | $244 | Form 4 |
| Aug 26, 2026 | Jacques Wolf SancheDirector | Bought | 4,150 | $45.02 | $186,833 | Form 4 |
| Aug 25, 2026 | Denise R SingletonChief Legal Officer & Corp Sec | Bought | 3,500 | $44.12 | $154,420 | Form 4 |
| Aug 25, 2026 | Nollaig ForrestChief Mktg & Corp Affairs Off | Bought | 1,500 | $44.15 | $66,225 | Form 4 |
| Aug 17, 2026 | Samuel Jonas PolettiChief Strategy & M&A Officer | Bought | 2,510 | $46.92 | $117,769 | Form 4 |
| Aug 12, 2026 | Baris OranChief Financial Officer | Bought | 3,000 | $47.13 | $141,390 | Form 4 |
| Aug 11, 2026 | Stephen S ClarkChief People Officer | Bought | 5,260 | $47.31 | $248,851 | Form 4 |
| Aug 11, 2026 | Mario GrossChief Supply Chain Officer | Bought | 3,568 | $46.60 | $166,252 | Form 4 |
| Aug 11, 2026 | Baris OranChief Financial Officer | Bought | 3,000 | $47.38 | $142,140 | Form 4 |
| Aug 11, 2026 | Jaime HillPresident, Building Materials | Bought | 1,500 | $47.12 | $70,680 | Form 4 |
| Aug 11, 2026 | Roald BrouwerChief Technology Officer | Bought | 1,500 | $46.36 | $69,540 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY24 | FY25 |
|---|---|---|
| Piotroski F-score | — | — |
| Rule of 40 | 14.2% | 13.0% |
| Altman Z'' | 1.98 | 2.41 |
| Accruals ratio | — | −4.3% |
The nine F-score tests
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | — | Pass |
| Cash from operations is positive | Pass | Pass |
| Return on assets rose | — | — |
| Cash from operations exceeds net income | Pass | Pass |
| Debt fell relative to assets | — | — |
| Current ratio rose | — | Fail |
| Share count didn't rise | Pass | Fail |
| Gross margin rose | Pass | Fail |
| Revenue rose relative to assets | — | — |
| F-score | — | — |
Compare
Put Amrize side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Amrize | FY25 | 0.9% | 16.1% | 12.0% | — | — | — | |
| Vulcan Materials | FY25 | 7.1% | 20.4% | 14.3% | 9.8% | 1.8x | 8 | Compare |
| Martin Marietta Materials | FY25 | 8.6% | 23.4% | 15.9% | 7.7% | 2.7x | 7 | Compare |
| CRH | FY25 | 5.3% | 14.5% | 7.8% | 11.8% | 1.9x | 7 | Compare |
| Knife River | FY25 | 8.5% | 9.1% | −2.2% | 9.1% | 2.3x | 3 | Compare |
3 years of figures
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | 11,677 | 11,704 | 11,815 |
| Revenue growth | — | 0.2% | 0.9% |
| Gross profit | 2,769 | 3,070 | 3,034 |
| Research and development | — | — | — |
| Operating income | 1,888 | 2,195 | 1,906 |
| Net income | 956 | 1,274 | 1,185 |
| Diluted EPS (US$) | 1.73 | 2.30 | 2.14 |
| Diluted shares (millions) | 553 | 553 | 554 |
| Cash flow | |||
| Cash from operations | 2,036 | 2,282 | 2,208 |
| Capital expenditure | 630 | 642 | 788 |
| Free cash flow | 1,406 | 1,640 | 1,420 |
| Dividends paid | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 |
| Acquisitions | 1,607 | 249 | 86 |
| Stock-based compensation | 5 | 6 | 14 |
| Balance sheet at fiscal year end | |||
| Cash and short-term investments | 1,107 | 1,585 | 1,922 |
| Debt incl. finance leases | — | — | — |
| Total assets | — | 23,805 | 24,249 |
| Total liabilities | — | 13,891 | 10,995 |
| Shareholders' equity | 9,203 | 9,915 | 13,258 |
| Margins and ratios | |||
| Gross margin | 23.7% | 26.2% | 25.7% |
| Operating margin | 16.2% | 18.8% | 16.1% |
| Net margin | 8.2% | 10.9% | 10.0% |
| Free cash flow margin | 12.0% | 14.0% | 12.0% |
| Rule of 40 (growth + FCF margin) | — | 14.2% | 13.0% |
| Return on capital | — | — | — |
| Return on equity | — | — | 10.2% |
| Return on assets | — | — | 4.9% |
| Net debt to EBITDA | — | — | — |